ULCERATIVE COLITIS
Clinical trials for ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Home test tracks gut Drug's Real-World impact
Disease control TerminatedThis study aimed to gather real-world information on how well the drug tofacitinib works for people with moderate to severe ulcerative colitis. It involved 18 participants in Switzerland who were prescribed the drug as part of their normal care. Researchers tracked their symptoms…
Matched conditions: ULCERATIVE COLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 03, 2026 19:41 UTC
-
Could a common gut molecule calm a painful surgical complication?
Disease control TerminatedThis study tested whether a pill called ursodeoxycholic acid (UDCA), a type of bile acid, could help control inflammation and improve quality of life in people with a condition called pouchitis. Pouchitis is a painful inflammation that can occur in a surgically created pouch afte…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2, PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Extended ulcerative colitis drug trial seeks Long-Term safety data
Disease control TerminatedThis study aimed to evaluate the long-term safety and effectiveness of the drug efavaleukin alfa in people with moderate to severe ulcerative colitis. It was an extension study for 25 participants who had completed a previous 52-week trial. The main goal was to monitor side effec…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Early-Stage trial for gut disease pill halted
Disease control TerminatedThis study tested an experimental oral medicine, PF-07054894, to see if it could help control ulcerative colitis. It involved 44 adults with mild to severe forms of the disease who hadn't responded well to standard treatments. The trial was terminated early, and its main goal was…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New ulcerative colitis drug goes Head-to-Head with standard treatment
Disease control TerminatedThis study aimed to see if a new drug called AVT16 works as well as the existing drug Entyvio for controlling moderate to severe ulcerative colitis. It involved about 300 adults and directly compared the two treatments over a year. The study was designed to be fair, with neither …
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Gut bacteria treatment tested for bowel disease
Disease control TerminatedThis study tested VE202, a treatment made from specific live bacteria, in people with mild-to-moderate ulcerative colitis (UC). The goal was to see if changing the gut's bacterial community could safely reduce bowel inflammation and improve symptoms. The trial was terminated earl…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug tested to calm severe bowel disease
Disease control TerminatedThis study tested a new drug called efavaleukin alfa in adults with moderate to severe ulcerative colitis, a chronic bowel disease. The main goal was to see if the drug could help patients achieve remission, meaning their symptoms and bowel inflammation went away. The trial was d…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Heart drug trial halted for bowel disease
Disease control TerminatedThis study tested whether common cholesterol-lowering drugs called statins could help control ulcerative colitis by changing the mix of bacteria in the gut. It involved 177 adults with mild to moderate ulcerative colitis or Crohn's disease who were not already taking statins. The…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Experimental drug tested for Hard-to-Treat bowel disease
Disease control TerminatedThis study tested an experimental drug called vixarelimab in people with moderate to severe ulcerative colitis who hadn't responded well to other treatments. The trial aimed to see if the drug could reduce bowel inflammation and symptoms over 12 weeks, and then explore longer-ter…
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC